Back to mobile site
Get it on Google Play

Annexon to present Phase 2 GA trial data at ASRS 2026 meeting

July 14, 2026 4:05 PM EDT Send to a Friend
Annexon, Inc. (NASDAQ: ANNX) announced it will deliver an oral presentation at the American Society of Retina Specialists 44th Annual ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login